CRYM Stock Overview
Develops and licenses equipment to refine harvested cannabis, hemp, and other premium crops in the United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Cryomass Technologies Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.034 |
52 Week High | US$0.14 |
52 Week Low | US$0.021 |
Beta | 0.29 |
11 Month Change | -24.27% |
3 Month Change | -15.75% |
1 Year Change | -76.04% |
33 Year Change | -88.38% |
5 Year Change | -94.97% |
Change since IPO | -94.14% |
Recent News & Updates
Recent updates
Shareholder Returns
CRYM | US Machinery | US Market | |
---|---|---|---|
7D | -0.3% | -1.6% | -2.4% |
1Y | -76.0% | 11.2% | 17.5% |
Return vs Industry: CRYM underperformed the US Machinery industry which returned 11.2% over the past year.
Return vs Market: CRYM underperformed the US Market which returned 17.5% over the past year.
Price Volatility
CRYM volatility | |
---|---|
CRYM Average Weekly Movement | 28.2% |
Machinery Industry Average Movement | 5.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CRYM's share price has been volatile over the past 3 months.
Volatility Over Time: CRYM's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | n/a | Christian Noel | cryomass.com |
Cryomass Technologies Inc., together with its subsidiaries, develops and licenses equipment to refine harvested cannabis, hemp, and other premium crops in the United States. It offers CryoSift Separator, which capture intact cannabis and hemp trichomes. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021.
Cryomass Technologies Inc. Fundamentals Summary
CRYM fundamental statistics | |
---|---|
Market cap | US$7.93m |
Earnings (TTM) | -US$13.91m |
Revenue (TTM) | US$18.85k |
420.6x
P/S Ratio-0.6x
P/E RatioIs CRYM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CRYM income statement (TTM) | |
---|---|
Revenue | US$18.85k |
Cost of Revenue | US$0 |
Gross Profit | US$18.85k |
Other Expenses | US$13.93m |
Earnings | -US$13.91m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.059 |
Gross Margin | 100.00% |
Net Profit Margin | -73,794.14% |
Debt/Equity Ratio | -71.6% |
How did CRYM perform over the long term?
See historical performance and comparison